Healthcare - Biotechnology - NASDAQ - US
$ 2.58
45.8 %
$ 6.99 M
Market Cap
-0.6
P/E
BALANCE SHEET
13.4 M
ASSETS
2.09 M
LIABILITIES
11.3 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Cyclerion Therapeutics, Inc.
| Current Assets | 8.02 M |
| Cash & Short-Term Investments | 7.57 M |
| Receivables | 0 |
| Other Current Assets | 453 K |
| Non-Current Assets | 5.35 M |
| Long-Term Investments | 5.35 M |
| PP&E | 0 |
| Other Non-Current Assets | 0 |
| Current Liabilities | 2.09 M |
| Accounts Payable | 1.2 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 888 K |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | ||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 7.6 | 13.4 | 54.0 | 54.4 | 94.9 | 0 | 0 | |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Receivables | 0 | 96 K | 100 K | 0.1 | 1.5 | 0 | 0 | |
| Inventory | 0 | 0.8 | 0.9 | 0.8 | 2.0 | 0 | 0 | |
| Other Current Assets | 0.5 | 1.3 | 1.4 | 4.0 | 4.8 | 0.9 | 1.3 | |
| Total Current Assets | 8.0 | 14.8 | 55.5 | 58.5 | 101.2 | 0.9 | 1.3 | |
| PP&E | 0 | 1.2 | 1.5 | 50.3 | 79.8 | 6.5 | 4.1 | |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Long Term Investments | 5.3 | 0 | 0 | 3.8 | 5.0 | 0 | 0 | |
| Other Long Term Assets | 0 | 2.0 | 2.4 | 2.8 | 0.5 | 25 K | 80 K | |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Assets | 13.4 | 18.1 | 59.3 | 115.4 | 186.5 | 7.4 | 5.5 | |
| LIABILITIES | ||||||||
| Accounts Payable | 1.2 | 3.0 | 1.8 | 1.4 | 3.3 | 2.8 | 1.8 | |
| Short Term Debt | 0 | 0 | 0 | 6.8 | 6.8 | 0 | 0 | |
| Other Current Liabilities | 0.9 | 4.7 | 9.3 | 8.7 | 8.1 | 15.1 | 12.2 | |
| Total Current Liabilities | 2.1 | 7.6 | 11.1 | 17.0 | 18.2 | 17.8 | 14.0 | |
| Long Term Debt | 0 | 0 | 0 | 38.9 | 70.5 | 0 | 0 | |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Liabilities | 2.1 | 7.6 | 11.1 | 55.9 | 88.7 | 17.8 | 14.0 | |
| EQUITY | ||||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Retained Earnings | (264.4) | (259.2) | (215.1) | (163.4) | (85.6) | 0 | 0 | |
| Other Accumulative Comprehensive Income/Loss | 12 K | 20 K | 23 K | 27 K | 20 K | (15.5) | (15.9) | |
| Total Equity | 11.3 | 10.5 | 48.2 | 59.5 | 97.7 | (10.4) | (8.6) | |
| Total Liabilities and Equity | 13.4 | 18.1 | 59.3 | 115.4 | 186.5 | 7.4 | 5.5 | |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 2.3 | 2.2 | 2.0 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 |